|
USFDA inspection for Divi Labs
Hyderabad: Divi's Laboratories Ltd has announced
that its manufacturing facility located at Choutuppal
near here was inspected by the US Food and Drug Administration
(USFDA) during the first week of this month.
According to a company's press release, the USFDA had
expressed that the findings were acceptable and the company
received no `483' comments/observations. According to
the company, a 483 is given to any company when there
are objectionable findings or deficiencies with the facilities
or systems for compliance. The company currently has 12
drug master files for the US market.
Back
to News Review index page
Indian
FMCG market gets LG Care as a contender
Mumbai: LG Care has launched a range of premium
products across eight key consumer categories, including
toothpastes, shampoos, detergents, soaps and diapers.
The company also announced its plans to launch cleaners,
cosmetics and hairstyling products soon. The company said
that India is not only one of the fastest growing markets
in Asia, but also its sheer size and the potential of
the market coupled with low penetration levels makes it
very attractive for them to enter India.
Back
to News Review index page
Jubilant
issues FCCBs
New Delhi: Jubilant Organosys Ltd has announced
that the company has issued unsecured and unrated five-year
FCCBs (Foreign Currency Convertible Bonds) worth $35 million
to international investors. The FCCBs have a 15 per cent
conversion premium at Rs 818.23 per share. The company
has already filed an application to list the FCCBs on
the Singapore Stock Exchange.
The FCCB will be convertible to rupee stocks or GDRs at
the option of the holder. Application has also been filed
to list the GDRs on Luxemburg Stock Exchange when GDRs
are issued on conversion of the FCCBs. The proceeds of
the issue will be used partly to fund the recently announced
acquisitions of two pharmaceutical companies in Europe
for Euro 13.5 million as well as to finance the capital
expenditure for the company's expansion plans.
Back
to News Review index page
Dr
Reddy's buys Trigenesis
Hyderabad: Dr Reddy's Laboratories has announced
the acquisition of Trigenesis Therapeutics Inc, the US-based,
privately-owned skincare company at an investment outlay
of $11 million. The acquisition assumes significance for
the company, as it gives access to certain products and
proprietary drug delivery technology platforms to develop
a pipeline of drugs in the dermatology segment.
In a press release, Dr Reddy's said it would make additional
contractual payments during the course of development
of products and technology platforms, as well as royalties
on sales to Skye Pharma and Silva Foam of UK as per the
existing agreements with Trigenesis. With the US market
for dermatology products estimated at $6 billion in 2002
and global market in 2003 being worth $8 billion, Dr Reddy's
is upbeat on the prospects in these lucrative markets.
Back
to News Review index page
Wockhardt acquires German firm
Esparma
Mumbai: Wockhardt Ltd has acquired a German pharma
company called Esparma Gmbh for $11 million (Rs 49 crore).
Wockhardt has set up a company called Wockhardt Germany,
GmbH to facilitate the acquisition. The acquisition covers
the company's businesses, sales and marketing organization
along with its name but not its manufacturing facility
which have been sold to another buyer.
Wockhardt
will continue to manufacture at these facilities for a
period of two years, after which Wockhardt will shift
manufacturing to its other existing facilities in the
UK and India.
This is the third acquisition for Wockhardt. In 1998,
it acquired Wallis Laboratories of the UK and CP Pharmaceuticals
in 2003. With this acquisition, Europe will account for
40 per cent of Wockhardt's total sales; 40 per cent will
come from India and 10 per cent each from the US and the
rest of the world.
Back
to News Review index page
Toyota
sales up 75 per cent for April
Bangalore: Toyota Kirloskar Motor (TKM) sales have
grown 75 per cent to 4,148 vehicles in April 2004 compared
with the same period a year ago. A press statement from
Toyota said the company sold 3,333 Qualis in April 2004
compared with 1,720 units in the corresponding month last
year, a growth of 94 per cent. Corolla sold 745 units,
posting a 30 per cent increase in sales. Toyota also sold
70 units of its luxury car Camry in April 2004.
Back
to News Review index page
Tata Motors April sales up 57 per cent
Mumbai: Tata Motors vehicle sales has registered
a growth of 57.7 per cent for the month of April 2004,
with a total sale of 24,961 vehicles, including exports,
as against a sale of 15,829 vehicles sold in April last
year. Sale of commercial vehicles in April 2004, in the
domestic market were 12,050 which is an increase of 71.2
per cent over the sales in April last year, while the
passenger car business has reported a total sale of 11,976
vehicles in the domestic market in April 2004, an increase
of 51 per cent. Indica sales were at 7,251- an increase
of 43.3 per cent. According to the release Indigo has
begun the new financial year still in the lead in the
entry midsize segment even after 16 months of the launch.
Back
to News Review index page
Motorola launches GSM phone
New Delhi: Motorola India has launched a high-end
mobile phone which allows the user to access corporate
e-mails, surf Internet, download music and stream video
on the handset. Priced at Rs 25,995, the Motorola MPx200
has been developed jointly with Microsoft and will be
initially sold exclusively through Hutch outlets in India.
The handset works on the Global Standard for Mobile platform.
Back
to News Review index page
Sun
and Paradox to partner for gaming
Bangalore: SUN Microsystems has announced that
it was partnering with Paradox Studios, a Reliance Group
company, to boost the market for gaming in the country
and further propagate the adoption of J2ME among gaming
developers. J2ME provides an application environment that
specifically addresses the needs of commodities in the
vast and rapidly growing consumer and embedded space,
including mobile phones, pagers, personal digital assistants,
set-top boxes, and vehicle telematics systems. This mutually
beneficial tie-up will see Sun partnering with Paradox
on technology innovations for the gaming industry and
open up global markets for Paradox to further propagate
J2ME-based games, said a Sun release.
Back
to News Review index page
Trend
Micro puts out Network Virus Wall
Mumbai: Trend Micro has introduced the Network
Virus Wall that allows potential threats to be scanned,
detected and blocked in an organisation's network. The
Trend Micro Enterprise protection strategy aims to provide
a solution against such threats, and enables anti-virus
policy enforcement within organisations. The Network Virus
Wall enables network security administrators to control
or limit access by non-compliant devices in a network.
The
appliance deployed at network LAN segments includes network-monitoring
features to help identify sources of infection, providing
enterprises with early warning to potential attacks. The
new prevention appliance enables security administrators
to use threat-specific knowledge to block network viruses
and identify vulnerable or non-compliant networked devices.
This helps to eliminate their ability to be a propagation
point for internal outbreaks.
Back
to News Review index page
Henko
cuts prices on the Stain Champion
Chennai: Henkel Spic India Ltd has relaunched its
Rs 100-crore lead brand Henko Stain Champion and cut prices
by about 15 per cent. The 3-kg pack costs Rs 225 from
the earlier Rs 265; the 1-kg pack is available at Rs 75
as against the earlier Rs 90 and the price of the 500-gm
pack has come down to Rs 38 from Rs 46. The sachet price
remains the same at Rs 2. The product has been relaunched
in gusset packs to enable more visibility and is backed
by a multimedia campaign. It would be endorsed by two
film actresses, Urmila Matondkar in the Hindi belt and
Laila in the four Southern States.
Back
to News Review index page
|
